This topic contains a solution. Click here to go to the answer

Author Question: Why are there more than two treatment levels in a one factor repeated measures design? a. Two ... (Read 73 times)

ss2343

  • Hero Member
  • *****
  • Posts: 548
Why are there more than two treatment levels in a one factor repeated measures design?
 
  a. Two levels don't allow enough time for some treatments to take effect.
  b. Having more than two treatment levels prevents the effects of maturation, testing, and history from occurring.
  c. To prevent the participants from having to perform the experimental task too many times.
  d. Certain relationships between variables cannot be accurately demonstrated with only two treatment levels.

Question 2

In the one factor repeated measures design, the number of treatment conditions is symbolized by _____.
 
  a. k c. N
  b. O d. df



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

dyrone

  • Sr. Member
  • ****
  • Posts: 322
Answer to Question 1

D
Certain complex relationships between variables cannot be discovered if there are only two levels of the independent variable; for example if responding increases at first and later declines with increasing levels of the independent variable, at leas three levels would be needed to demonstrate the relationship.

Answer to Question 2

A
The number of treatments in the one factor repeated measures design is similar to the number of groups in the one factor between subjects design. Both are represented by the symbol k.




ss2343

  • Member
  • Posts: 548
Reply 2 on: Jun 19, 2018
Gracias!


bassamabas

  • Member
  • Posts: 294
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Methicillin-resistant Staphylococcus aureus or MRSA was discovered in 1961 in the United Kingdom. It if often referred to as a superbug. MRSA infections cause more deaths in the United States every year than AIDS.

Methicilli ...
Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Side effects from substance abuse include nausea, dehydration, reduced productivitiy, and dependence. Though these effects usually worsen over time, the constant need for the substance often overcomes rational thinking.

Did you know?

In 1864, the first barbiturate (barbituric acid) was synthesized.

For a complete list of videos, visit our video library